I have to say, this is the first time in a year that I have bothered to log into this website. I am hoping @bethesda listens to their customers. #Fallout76
@bethesda As a person who plays #fallout76 primarily to build camps, taking out the flamer trap merge trick is a low blow. So many of us have spent so much time and money building in your game. Do not do us dirty. People will leave over this kind of thing.
@bethesda As a person who plays #fallout76 primarily to build camps, taking out the flamer trap merge trick is a low blow. So many of us have spent so much time and money building in your game. Do not do us dirty. People will leave over this kind of thing.
So long to the @cartoonnetwork building, a place that will always hold special meaning for me. The place where, once the imposter syndrome wore off, I was able to look around the booth and see people I’d heard in animation all my life and think… “just mayyyybe I can do this.” 😅
@JNJNews You turned off the comments to the tweet so it couldn't be refuted directly, cowards. Please do the right thing and let the patent for Bedaquiline expire.
https://t.co/ugN2xCdReL
It is false to suggest—as some recently have—that our patents are being used to prevent access to SIRTURO® (bedaquiline), our medicine for MDR-TB.
In fact, we have already entered into a collaboration with the Stop TB Partnership’s Global Drug Facility (“GDF”)—the largest procurer of TB medicines—which enables them to invite potential generic suppliers and purchase generic versions of SIRTURO® 100mg. On April 5, during a World Health Organization meeting, the GDF shared its intent to launch a tender for generic versions of SIRTURO® 100mg in the third quarter of 2023: https://t.co/6m49h5g7tn
In addition, we have shipped more than 660,000 courses of SIRTURO® to 159 countries since launch. Our patents made this possible, enabling us to assist countries to scale-up their use of our medicine responsibly and sustainably and invest in multiple, critical, anti-TB efforts. For instance, in the face of rising drug resistance, we support stewardship efforts that ensure MDR-TB patients can benefit from our medicine today and in the future.
Unfortunately, the most significant barrier to treatment access for patients today is the fact that millions of patients with TB go undiagnosed every year. This is a challenge that we have invested significant resources to overcome and must all get behind if we are to achieve the global goal of ending TB.
Voice actors can see a terrible reality looming and are being met with a horrifying lack of understanding.
“Fair use. People will do what they want. I’m not making money off of it.” These arguments break down with even basic logic and empathy. I’m sad for Erica. Please listen.